JP2014227379A5 - - Google Patents

Download PDF

Info

Publication number
JP2014227379A5
JP2014227379A5 JP2013108664A JP2013108664A JP2014227379A5 JP 2014227379 A5 JP2014227379 A5 JP 2014227379A5 JP 2013108664 A JP2013108664 A JP 2013108664A JP 2013108664 A JP2013108664 A JP 2013108664A JP 2014227379 A5 JP2014227379 A5 JP 2014227379A5
Authority
JP
Japan
Prior art keywords
butea
extract
dysfunction
impairment
sperva
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013108664A
Other languages
Japanese (ja)
Other versions
JP2014227379A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2013108664A priority Critical patent/JP2014227379A/en
Priority claimed from JP2013108664A external-priority patent/JP2014227379A/en
Publication of JP2014227379A publication Critical patent/JP2014227379A/en
Publication of JP2014227379A5 publication Critical patent/JP2014227379A5/ja
Pending legal-status Critical Current

Links

Claims (8)

ブテア スペルバ又はその抽出物を有効成分とする抗認知機能障害剤。   An anticognitive dysfunction agent containing butea sperva or an extract thereof as an active ingredient ブテア スペルバの抽出物がブテア スペルバの低級アルコール抽出物である請求項１記載の抗認知機能障害剤。   The anticognitive dysfunction agent according to claim 1, wherein the extract of Butea sperva is a lower alcohol extract of Butea sperva. 低級アルコールがエタノールである請求項２記載の抗認知機能障害剤。   The anticognitive dysfunction agent according to claim 2, wherein the lower alcohol is ethanol. 認知機能障害が、短期記憶障害、長期記憶障害、物体認識記憶障害又は空間記憶障害である請求項１〜３のいずれか１項記載の抗認知機能障害剤。   The anticognitive dysfunction agent according to any one of claims 1 to 3, wherein the cognitive dysfunction is short-term memory disorder, long-term memory disorder, object recognition memory disorder or spatial memory disorder. ブテア スペルバ又はその抽出物を有効成分とする認知機能障害の予防又は改善用食品組成物。A food composition for preventing or improving cognitive dysfunction comprising butea sperva or an extract thereof as an active ingredient. ブテア スペルバの抽出物がブテア スペルバの低級アルコール抽出物である請求項５記載の認知機能障害の予防又は改善用食品組成物。The food composition for preventing or improving cognitive dysfunction according to claim 5, wherein the extract of Butea sperba is a lower alcohol extract of Butea sperba. 低級アルコールがエタノールである請求項６記載の認知機能障害の予防又は改善用食品組成物。The food composition for preventing or improving cognitive dysfunction according to claim 6, wherein the lower alcohol is ethanol. 認知機能障害が、短期記憶障害、長期記憶障害、物体認識記憶障害又は空間記憶障害である請求項５〜７のいずれか１項記載の認知機能障害の予防又は改善用食品組成物。The food composition for preventing or improving cognitive impairment according to any one of claims 5 to 7, wherein the cognitive impairment is short-term memory impairment, long-term memory impairment, object recognition memory impairment or spatial memory impairment.
JP2013108664A 2013-05-23 2013-05-23 Agents against cognitive function disorder Pending JP2014227379A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013108664A JP2014227379A (en) 2013-05-23 2013-05-23 Agents against cognitive function disorder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013108664A JP2014227379A (en) 2013-05-23 2013-05-23 Agents against cognitive function disorder

Publications (2)

Publication Number Publication Date
JP2014227379A JP2014227379A (en) 2014-12-08
JP2014227379A5 true JP2014227379A5 (en) 2016-06-30

Family

ID=52127565

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013108664A Pending JP2014227379A (en) 2013-05-23 2013-05-23 Agents against cognitive function disorder

Country Status (1)

Country Link
JP (1) JP2014227379A (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2643973A1 (en) * 2006-02-28 2007-09-07 Council Of Scientific And Industrial Research Pharmaceutical composition containing butea isoflavones for the prevention /treatment of bone disorders and a process for the preparation thereof

Similar Documents

Publication Publication Date Title
JP2015503422A5 (en)
JP2015506787A5 (en)
JP2012106006A5 (en)
JP2014515597A5 (en)
JP2014237817A5 (en)
EP4309735A3 (en) Pharmaceutical composition of s-ketamine hydrochloride
JP2014517802A5 (en)
JP2016182547A5 (en)
JP2015505555A5 (en)
JP2015510021A5 (en)
WO2014153495A9 (en) Novel stat3 inhibitors
JP2015173751A5 (en)
DK3402785T3 (en) 3- (carboxymethyl) -8-amino-2-oxo-1,3-diaza-spiro [4.5] decane-DERIVATIVES
FR3027522B1 (en) POROUS COMPOSITION CHARGED AS ACTIVE
FR3013964B1 (en) COMPOSITION COMPRISING AQUEOUS MEDIUM
JP2015529327A5 (en)
BR112016012233A2 (en) compositions comprising cinnamaldehyde, and its uses
FR3013338B1 (en) STRUCTURE OF THE CONTAINER CAP.
WO2015044434A3 (en) Fluor-9-methyl-β-carbolines
JP2014227379A5 (en)
ES1078895Y (en) ROLLING TABLE
JP2016210695A5 (en)
JP2014227380A5 (en)
WO2015190808A3 (en) Whitening ability of small stem cell and use thereof
JP2014189771A5 (en)